Telescope Strengthens Investor Communications Strategy Ready to Announce with Confidence?
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries,has rescoped its previously announced digital marketing agreement dated September 19, 2025, with Gold Standard Media, LLC ("GSM") and its affiliates. In connection with the reduction in scope GSM has refunded the Company $300,000 in previously paid fees so that Telescope is able to use an additional marketing vehicle to support its Investor Marketing activities.
The Company further announces that it has engaged Curzio Research Holdings, LLC ("Curzio") to provide the Company with marketing services, including digital marketing, targeted media relations, ongoing market awareness and strategic council to the Company (the "Curzio Services"). In consideration for the Curzio Services, Curzio will receive an aggregate upfront payment of USD$300,000. The Curzio marketing and consulting agreement (the "Agreement") has a three-month term, which commenced on March 1, 2026, unless terminated earlier in accordance with the terms of the Agreement. Curzio and its principal and Chief Executive Officer, Frank Curzio, are at arm's length to the Company and have advised they do not own any securities in the Company.
Curzio is a US based company and can be contacted at (844) 592-9944 and by email at support@curzioresearch.com.
About Telescope Innovations
Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. The Company's aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.
On behalf of the Board,
Telescope Innovations Corp.
Henry Dubina, Chief Executive Officer
443-994-2182
For additional information, please contact
Jeffrey Sherman, Ph.D.
E: jeff.sherman@telescopeinn.com
Forward-Looking Information
The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain certain "forward-looking information" under applicable Canadian securities laws. When or if used in this news release, the words "anticipate," "believe," "estimate," "expect", "intend", "target", "plan," "forecast," "may," "schedule," and similar words or expressions identify forward-looking information. This forward-looking information may relate to planned project development, exploration programs, success of the Agreement and other factors or information.
Forward-looking information is based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information.
The forward-looking information contained in this news release is made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/288211
Source: Telescope Innovations Corp.
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Telescope Innovations Corp. or all companies in the Technology, Chemical, Pharmaceuticals industry.
Telescope Strengthens Investor Communications Strategy
2026-03-12 8:30 AM EDT
Telescope Innovations Installs Second Self-Driving Lab at Pfizer
2026-02-23 8:00 AM EST
Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026
2026-01-30 7:28 PM EST
Dec 16, 2025
What makes a press release rise above the rest? We analyzed the most successful press releases of 2025 to see what caught attention and why. This year’s review looks at total views from human readers and AI systems across the top five hundred public company press releases distributed through TMX Newsfile in 2025. These views come from all of Newsfile’s general distribution channels, such as Yahoo and Apple. They reflect how audiences discovered and engaged with each announcement. Key Insights...
Economy, Business and Finance
Chemicals
Pharmaceutical
Science and Technology
Technology
Chemical
Pharmaceuticals